Events

_{Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements that are not historical facts contained in releases or in our posted events and presentations are forward-looking statements that involve risks and uncertainties, including, but not limited to, the results of research and development efforts, the results of preclinical and clinical testing, the effect of regulation by government authorities, including the FDA and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the company’s Securities and Exchange Commission filings. You should not place undue reliance on forward-looking statements in such releases and postings, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein and within such releases and postings. Spyre does not undertake any obligation to update forward-looking statements after the date of such releases and postings except to the extent required under applicable federal and state securities laws.}

_{This website contains links to websites maintained by other companies. Spyre is providing these links to readers only as a convenience. The inclusion of any link does not imply that Spyre endorses any third-party website or third-party company or product. Spyre does not have any control over the content of such third-party websites and assumes no responsibility whatsoever for the functionality or the accuracy of any information presented at such websites.}